促进艾滋病药物的获取，同时保持强有力的专利保护。

Duke law and technology review Pub Date : 2001-12-07

D Ziker

{"title":"促进艾滋病药物的获取，同时保持强有力的专利保护。","authors":"D Ziker","doi":"","DOIUrl":null,"url":null,"abstract":"The AIDS pandemic has thrust the subject of patent protection into the spotlight, a spotlight that has attracted the attention of broad audience including interested parties from the political, legal, and medical communities. Can the United States' scheme of strong patent protection for pharmaceutical products withstand the increased attention?","PeriodicalId":87176,"journal":{"name":"Duke law and technology review","volume":" ","pages":"E1"},"PeriodicalIF":0.0000,"publicationDate":"2001-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Facilitating access of AIDS drugs while maintaining strong patent protection.\",\"authors\":\"D Ziker\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The AIDS pandemic has thrust the subject of patent protection into the spotlight, a spotlight that has attracted the attention of broad audience including interested parties from the political, legal, and medical communities. Can the United States' scheme of strong patent protection for pharmaceutical products withstand the increased attention?\",\"PeriodicalId\":87176,\"journal\":{\"name\":\"Duke law and technology review\",\"volume\":\" \",\"pages\":\"E1\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2001-12-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Duke law and technology review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Duke law and technology review","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

艾滋病的流行使专利保护问题成为人们关注的焦点，引起了包括政界、法律界和医学界有关各方在内的广泛关注。美国对药品强有力的专利保护方案能否经受住日益增加的关注?

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Facilitating access of AIDS drugs while maintaining strong patent protection.

The AIDS pandemic has thrust the subject of patent protection into the spotlight, a spotlight that has attracted the attention of broad audience including interested parties from the political, legal, and medical communities. Can the United States' scheme of strong patent protection for pharmaceutical products withstand the increased attention?

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Duke law and technology review

自引率

0.00%

发文量